Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
3.220
-0.010 (-0.31%)
At close: Nov 4, 2024, 4:00 PM
3.230
+0.010 (0.31%)
After-hours: Nov 4, 2024, 5:30 PM EST
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 377 employees as of December 31, 2023. The number of employees increased by 22 or 6.20% compared to the previous year.
Employees
377
Change (1Y)
22
Growth (1Y)
6.20%
Revenue / Employee
$481,202
Profits / Employee
-$157,995
Market Cap
479.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Emergent BioSolutions | 1,600 |
Health Catalyst | 1,300 |
Definitive Healthcare | 950 |
Valneva SE | 676 |
Paragon 28 | 574 |
Alector | 244 |
Arcturus Therapeutics Holdings | 180 |
PureTech Health | 90 |
XERS News
- 4 days ago - Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024 - Business Wire
- 10 days ago - Xeris Biopharma Holdings: Promising Pipeline And Strategic Partnerships Make It Attractive - Seeking Alpha
- 24 days ago - Undercovered Dozen: KinderCare Learning, Xeris Biopharma, Generac, Philips + - Seeking Alpha
- 26 days ago - Xeris Biopharma: Time For A Reassessment - Seeking Alpha
- 4 weeks ago - Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Xeris to Participate in Upcoming Investor Conferences - Business Wire
- 3 months ago - Xeris Biopharma Holdings, Inc. (XERS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Xeris Biopharma Reports Second Quarter 2024 Financial Results - Business Wire